BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 33010280)

  • 1. Phosphoesterase complex modulates microflora and chronic inflammation in rats with alcoholic fatty liver disease.
    Ma D; Hu J; Xu W; Wang Y; Wang J; Li L; Wang S; Zhou H; Li Y; Liu L
    Life Sci; 2020 Dec; 262():118509. PubMed ID: 33010280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apple Polysaccharide inhibits microbial dysbiosis and chronic inflammation and modulates gut permeability in HFD-fed rats.
    Wang S; Li Q; Zang Y; Zhao Y; Liu N; Wang Y; Xu X; Liu L; Mei Q
    Int J Biol Macromol; 2017 Jun; 99():282-292. PubMed ID: 28238909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinctive gut microbial dysbiosis between chronic alcoholic fatty liver disease and metabolic-associated fatty liver disease in mice.
    Kang K; Sun Y; Pan D; Sang LX; Sun MJ; Li YL; Chang B
    Exp Ther Med; 2021 May; 21(5):418. PubMed ID: 33777186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GanMeijian ameliorates lipid accumulation and oxidative damage in alcoholic fatty liver disease in Wistar rats.
    Li Y; Sun Y; Zang Y; Su Y; Zhou H; Wang J; Xie M; Chen G; Liu L; Mei Q
    Life Sci; 2020 Aug; 255():117721. PubMed ID: 32360617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcoholic fatty liver disease inhibited the co-expression of Fmo5 and PPARα to activate the NF-κB signaling pathway, thereby reducing liver injury via inducing gut microbiota disturbance.
    Kong L; Chen J; Ji X; Qin Q; Yang H; Liu D; Li D; Sun M
    J Exp Clin Cancer Res; 2021 Jan; 40(1):18. PubMed ID: 33413501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
    Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
    Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier.
    Zhou D; Pan Q; Xin FZ; Zhang RN; He CX; Chen GY; Liu C; Chen YW; Fan JG
    World J Gastroenterol; 2017 Jan; 23(1):60-75. PubMed ID: 28104981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effect of flavonoids extract of Hippophae rhamnoides L. on alcoholic fatty liver disease through regulating intestinal flora and inhibiting TAK1/p38MAPK/p65NF-κB pathway.
    Zhao H; Kong L; Shao M; Liu J; Sun C; Li C; Wang Y; Chai X; Wang Y; Zhang Y; Li X
    J Ethnopharmacol; 2022 Jun; 292():115225. PubMed ID: 35341932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Astaxanthin Prevents Alcoholic Fatty Liver Disease by Modulating Mouse Gut Microbiota.
    Liu H; Liu M; Fu X; Zhang Z; Zhu L; Zheng X; Liu J
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30217037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allicin Modifies the Composition and Function of the Gut Microbiota in Alcoholic Hepatic Steatosis Mice.
    Panyod S; Wu WK; Lu KH; Liu CT; Chu YL; Ho CT; Hsiao WW; Lai YS; Chen WC; Lin YE; Lin SH; Wu MS; Sheen LY
    J Agric Food Chem; 2020 Mar; 68(10):3088-3098. PubMed ID: 32050766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet Supplementation with Allicin Protects against Alcoholic Fatty Liver Disease in Mice by Improving Anti-inflammation and Antioxidative Functions.
    Panyod S; Wu WK; Ho CT; Lu KH; Liu CT; Chu YL; Lai YS; Chen WC; Lin YE; Lin SH; Sheen LY
    J Agric Food Chem; 2016 Sep; 64(38):7104-13. PubMed ID: 27584700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary nucleotides protect against alcoholic liver injury by attenuating inflammation and regulating gut microbiota in rats.
    Cai X; Bao L; Wang N; Ren J; Chen Q; Xu M; Li D; Mao R; Li Y
    Food Funct; 2016 Jun; 7(6):2898-908. PubMed ID: 27247978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of intestinal bacteria with fatty liver diseases and cirrhosis.
    Guohong-Liu ; Qingxi-Zhao ; Hongyun-Wei
    Ann Hepatol; 2019; 18(6):796-803. PubMed ID: 31558417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic P2X7 receptor blockade mitigates alcohol-induced steatohepatitis and intestinal injury by regulating MEK1/2-ERK1/2 signaling and egr-1 activity.
    Su QQ; Tian YY; Liu ZN; Ci LL; Lv XW
    Int Immunopharmacol; 2019 Jan; 66():52-61. PubMed ID: 30445307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
    Shen SH; Zhong TY; Peng C; Fang J; Lv B
    BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combination of quercetin and resveratrol reduces obesity in high-fat diet-fed rats by modulation of gut microbiota.
    Zhao L; Zhang Q; Ma W; Tian F; Shen H; Zhou M
    Food Funct; 2017 Dec; 8(12):4644-4656. PubMed ID: 29152632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis.
    Zhang T; Li J; Liu CP; Guo M; Gao CL; Zhou LP; Long Y; Xu Y
    Ann Transl Med; 2021 May; 9(10):873. PubMed ID: 34164507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice.
    Ferrere G; Wrzosek L; Cailleux F; Turpin W; Puchois V; Spatz M; Ciocan D; Rainteau D; Humbert L; Hugot C; Gaudin F; Noordine ML; Robert V; Berrebi D; Thomas M; Naveau S; Perlemuter G; Cassard AM
    J Hepatol; 2017 Apr; 66(4):806-815. PubMed ID: 27890791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction.
    Shao T; Zhao C; Li F; Gu Z; Liu L; Zhang L; Wang Y; He L; Liu Y; Liu Q; Chen Y; Donde H; Wang R; Jala VR; Barve S; Chen SY; Zhang X; Chen Y; McClain CJ; Feng W
    J Hepatol; 2018 Oct; 69(4):886-895. PubMed ID: 29803899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Tea against Alcoholic Fatty Liver Disease by Modulating Gut Microbiota in Chronic Alcohol-Exposed Mice.
    Li B; Mao Q; Zhou D; Luo M; Gan R; Li H; Huang S; Saimaiti A; Shang A; Li H
    Foods; 2021 May; 10(6):. PubMed ID: 34071491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.